Literature DB >> 10557032

Lack of association between a human beta-2 adrenoceptor gene polymorphism (gln27glu) and morbid obesity.

B Kortner1, A Wolf, D Wendt, U Beisiegel, D Evans.   

Abstract

OBJECTIVE: To determine the frequency of the gln27glu polymorphism in the beta-2 adrenoceptor gene in patients with morbid obesity.
SUBJECTS: 243 patients with morbid obesity (mean body mass index 51. 6) and 199 healthy blood donors.
RESULTS: The same frequency, 0.42, of the glu allele was observed in both groups. Neither the incidence in obese women (0.41, n=197) compared to control women (0.43, n=61), nor that in obese men (0.44, n=46) compared to control men (0.41, n=138) was significantly different. The difference in frequency between obese men and women, 0.44 vs 0.41 was not significant (P=0. 68). Genotype information from the families of 18 of the obese patients showed no association between the glu27 allele and BMI.
CONCLUSIONS: We find no evidence for a role of the glu27 variant in the beta-2 adrenoceptor gene in the development of morbid obesity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557032     DOI: 10.1038/sj.ijo.0801063

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  12 in total

Review 1.  Beta-adrenoceptor polymorphisms.

Authors:  K Leineweber; R Büscher; H Bruck; O-E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-28       Impact factor: 3.000

2.  β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol.

Authors:  Orly Vardeny; Gabriel Nicholas; Alina Andrei; Kevin A Buhr; Matt P Hermanson; John J Moran; Michelle A Detry; James H Stein
Journal:  Am J Hypertens       Date:  2012-05-31       Impact factor: 2.689

3.  Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects.

Authors:  A P Gjesing; G Andersen; K S Burgdorf; K Borch-Johnsen; T Jørgensen; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2007-01-13       Impact factor: 10.122

4.  Inactivation of the adrenergic receptor β2 disrupts glucose homeostasis in mice.

Authors:  Gustavo W Fernandes; Cintia B Ueta; Tatiane L Fonseca; Cecilia H A Gouveia; Carmen L Lancellotti; Patrícia C Brum; Marcelo A Christoffolete; Antonio C Bianco; Miriam O Ribeiro
Journal:  J Endocrinol       Date:  2014-06       Impact factor: 4.286

5.  The Gln27Glu polymorphism in β2-adrenergic receptor gene is linked to hypertriglyceridemia, hyperinsulinemia and hyperleptinemia in Saudis.

Authors:  Maha H Daghestani; Arjumand Warsy; Mazin H Daghestani; Ali N Al-odaib; Abdelmoneim Eldali; Nadia A Al-Eisa; Sabah Al-zhrani
Journal:  Lipids Health Dis       Date:  2010-08-25       Impact factor: 3.876

6.  Individual Responsiveness to Exercise-Induced Fat Loss and Improvement of Metabolic Profile in Young Women is Associated with Polymorphisms of Adrenergic Receptor Genes.

Authors:  Agata Leońska-Duniec; Zbigniew Jastrzębski; Aleksandra Jażdżewska; Waldemar Moska; Ewelina Lulińska-Kuklik; Marek Sawczuk; Svetlana I Gubaydullina; Alsu T Shakirova; Pawel Cięszczyk; Adam Maszczyk; Ildus I Ahmetov
Journal:  J Sports Sci Med       Date:  2018-03-01       Impact factor: 2.988

7.  Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.

Authors:  Kazuko Masuo
Journal:  Int J Hypertens       Date:  2010-10-21       Impact factor: 2.420

8.  Relationships of adrenoceptor polymorphisms with obesity.

Authors:  Kazuko Masuo; Gavin W Lambert
Journal:  J Obes       Date:  2011-04-04

9.  Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus.

Authors:  Michele Pinelli; Manuela Giacchetti; Fabio Acquaviva; Sergio Cocozza; Giovanna Donnarumma; Emanuela Lapice; Gabriele Riccardi; Geremia Romano; Olga Vaccaro; Antonella Monticelli
Journal:  BMC Med Genet       Date:  2006-12-06       Impact factor: 2.103

10.  Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer.

Authors:  X E Huang; N Hamajima; T Saito; K Matsuo; M Mizutani; H Iwata; T Iwase; S Miura; T Mizuno; S Tokudome; K Tajima
Journal:  Breast Cancer Res       Date:  2001-04-26       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.